Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Molecular Subtype Specific Stem Cell Dynamics in Developing and Established Colorectal Cancers

Project description

Origins of colorectal cancer heterogeneity

Colorectal cancer (CRC) is one of the most common types of cancer and a leading cause of cancer-related deaths worldwide. CRC is characterised by extensive heterogeneity, which contributes to its clinical variability and treatment response. Funded by the European Research Council, the CRCStemCellDynamics project aims to shed light on this inter-tumour variation by focusing on the cell of origin and the mutations that trigger tumour development from pre-malignant clones. Researchers will analyse the molecular profiles of human CRC samples and investigate the relevance of the cancer stem cell hypothesis. Collectively, the work is expected to enhance the classification, prevention, and treatment strategies for CRC.

Objective

Annually 1.2 million new cases of colorectal cancer (CRC) are seen worldwide and over 50% of patients die of the disease making it a leading cause of cancer-related mortality. A crucial contributing factor to these disappointing figures is that CRC is a heterogeneous disease and tumours differ extensively in the clinical presentation and response to therapy. Recent unsupervised classification studies highlight that only a proportion of this heterogeneity can be explained by the variation in commonly found (epi-)genetic aberrations. Hence the origins of CRC heterogeneity remain poorly understood.

The central hypothesis of this research project is that the cell of origin contributes to the phenotype and functional properties of the pre-malignant clone and the resulting malignancy. To study this concept I will generate cell of origin- and mutation-specific molecular profiles of oncogenic clones and relate those to human CRC samples. Furthermore, I will quantitatively investigate how mutations and the cell of origin act in concert to determine the functional characteristics of the pre-malignant clone that ultimately develops into an invasive intestinal tumour. These studies are paralleled by the investigation of stem cell dynamics within established human CRCs by means of a novel marker independent lineage tracing strategy in combination with mathematical analysis techniques. This will provide critical and quantitative information on the relevance of the cancer stem cell concept in CRC and on the degree of inter-tumour variation with respect to the frequency and functional features of stem-like cells within individual CRCs and molecular subtypes of the disease.
I am convinced that a better and quantitative understanding of the dynamical properties of stem cells during tumour development and within established CRCs will be pivotal for an improved classification, prevention and treatment of CRC.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

ERC-STG - Starting Grant

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2014-STG

See all projects funded under this call

Host institution

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM
Net EU contribution
€ 1 499 875,00
Address
MEIBERGDREEF 15
1105AZ Amsterdam
Netherlands
Region
West-Nederland Noord-Holland Groot-Amsterdam
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 499 875,00

Beneficiaries (1)